RAND Corporation   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Santa Monica CA United States (1948)

Organization Overview

First Clinical Trial
2006
NCT00347269
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

RAND | RaND Biosciences | RAND Corporation, Santa Monica, CA

Active Ingredients

Drugs in Phase 4 Trials (1)

buprenorphine (2 trials)

Drugs in Phase 3 Trials (1)

naloxone (narcan) (1 trial)

Drugs in Phase 2 Trials (2)

cisplatin (platinol) (1 trial)

sc-43 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 4)

Disease (Phase 4)

Panic Disorder (Phase 4)

Phobia, Social (Phase 4)

Stress Disorders, Post-Traumatic (Phase 4)

Stress Disorders, Traumatic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4